chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient is a 51 y.o. female with history of renal transplant (on immunosuppressants) and current COVID-19 infection who presented from home on 9/6/2022 with worsening dyspnea and cough, along with worsening renal function.  Nephrology and ID involved with care.  Fevers  COVID-19 pneumonia Patient overall feeling improved, symptoms are resolving.  Initially presented with worsening cough, dyspnea, fevers, diarrhea in the setting of COVID-19; tested positive 8/24 on home rapid test. Symptom onset ~8/19-8/20. CXR at COPC 9/2 suggestive of CHF, indeterminate pulmonary nodules within R lung; CXR in ED with diminished lung volumes and crowding of vasculature, faint opacity in R mid to lower lung zone; CT chest with patchy ground glass opacities likely consistent with COVID / viral pneumonitis  - pt fully vaccinated and boosted x 2; had Evushield in March 2022; could not get MAB and not a candidate for Paxlovid.  Monoclonal antibodies given during this hospitalization - TTE obtained, no evidence of overt volume overload -will continue isolation in the hospital and continue CDC guidelines in the outpatient setting.  We discussed ongoing isolation and mask wearing in the home setting given her recent fever. - ID consulted for guidance on further infectious work-up, appreciate recommendations   AKI on CKD 4 Hypovolemia, hyponatremia  History of kidney transplant History of metabolic acidosis With history of membranous nephropathy. S/p deceased donor transplant 6/1999 at OSU; functioned until 2011; then s/p cadaveric kidney transplant 3/30/2016 (second transplant); 11/30/20 transplant kidney biopsy with evidence of acute on chronic rejection with transplant glomerulopathy  - sCr 2.78 and Na 134 on admit 9/6; improved compared to COPC labs 9/2 which showed sCr 3.1, BUN 56 - baseline sCr ~2.1?2.3 - continue home immunosuppression regimen -Close to patient follow-up with her nephrologist in outpatient setting for recheck of renal function this upcoming week.   History of nonischemic CMP Elevated troponin No evidence of overt volume overload on exam.  Recovered EF; secondary to ESRD per OP notes.  Ongoing care in the outpatient setting   Hypertension  Home beta-blocker dose increased.   Pancytopenia History of anemia of CKD Hemoglobin 9.2, WBC 4.05, platelets 118 on admission 9/6. COPC labs 9/2 with Hgb 9.2, WBC 4.4, PLT 117. ESA per nephrology, started 4/2021, goal hemoglobin 10?11. Noted history of neutropenia due to higher dose Myfortic, resolved with reduction and use of steroids -Continue to follow counts in the outpatient setting  Hyperlipidemia Resume statin therapy on discharge
Information has been received from a physician concerning a 6 month old male with no pre-existing allergies, birth defects, or medical conditions who on 29-MAR-2007 at 6:00PM was vaccinated PO with a third dose of Rotateq (Lot # 656189/1239F). There was no illness at the time of vaccination. Concomitant therapy that day at 6:00PM included a third dose of IPOL (Lot # Z0326-2) administered IM in the left thigh, a third dose of Prevnar (Lot # B08640H) administered IM in the right thigh, and a third dose of Tripedia (Lot # C2552AA) administered IM in the left thigh. On 30-MAR-2007, one day after vaccination, the patient developed a rash around his rectum. The patient was seen 3 days later and had severe perirectal erythema. This was treated as cellulitis with improvement. No diarrhea was noted. The outcome was recovered on 09-APR-2007. There were no relevant diagnostic tests or laboratory date. There were no adverse events following prior vaccinations. The reporter considered the event to be an other important medical event. No additional information is expected.
On 07/26/2021, visual migraine halo, aphasia. I could not understand what people were saying and I couldn't speak back. I called 911 and took a ride in the ambulance to the ER. In the 2 hours I was in the ER, they did test and gave me 2 children's aspirin in 24 hours. I went to my GP, after a week 1/2, 08/05/2021, the doctor did not think I had a TIA. (The symptoms were pretty much like a stroke). He was confident that I had a complex migraine. On the 08/162021, I visited my cardiologist, he confirmed it was a complex migraine. I have no history of migraines.
Severe heart pounding and fast rate all night for about 8 hours in duration after receiving the shot about 13 hours later--could not sleep. Migraine headache for 3 days--had to remain in dark room on bed, and I still have a headache on the 5th day after the shot.  Very painful teeth, still ongoing.  Chills--possible fever, nausea, fatigue and arm site pain.
coughing; Initial information received on 02-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced coughing , after receiving vaccine INFLUENZA VACCINE.  The patient's past  medical treatment(s), vaccination(s) and family history were not provided.  It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date in Oct-2022, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer , with an unknown formulation and strength, (lot number and expiry date: not reported)  via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date in 01- Nov-2022, the patient developed a non-serious  event of coughing (cough) (unknown latency) following the administration of INFLUENZA VACCINE. At the time of repot, the patient still had cough.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (coughing).  At time of reporting, the outcome was Not Recovered / Not Resolved for the event coughing.
after a below freezing temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a female patient who received DTPa-HBV-IPV (Pediarix) (batch number mk944, expiry date 5th March 2023) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 19th July 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that, the patient was administrated with Pediarix after a below freezing temperature excursion, which led to incorrect storage of drug. No adverse event was reported. The reporter consented to follow up. This case was 1 of 29 linked cases, reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021164783:same reporter US-GLAXOSMITHKLINE-US2021164777:same reporter US-GLAXOSMITHKLINE-US2021164800:same reporter US-GLAXOSMITHKLINE-US2021164791:same reporter US-GLAXOSMITHKLINE-US2021164781:same reporter US-GLAXOSMITHKLINE-US2021164775:same reporter US-GLAXOSMITHKLINE-US2021164771:same reporter US-GLAXOSMITHKLINE-US2021164769:same reporter US-GLAXOSMITHKLINE-US2021164779:same reporter US-GLAXOSMITHKLINE-US2021164786: US-GLAXOSMITHKLINE-US2021164787: US-GLAXOSMITHKLINE-US2021164789: US-GLAXOSMITHKLINE-US2021164791: US-GLAXOSMITHKLINE-US2021164792: US-GLAXOSMITHKLINE-US2021164793: US-GLAXOSMITHKLINE-US2021164794: US-GLAXOSMITHKLINE-US2021164795: US-GLAXOSMITHKLINE-US2021164797: US-GLAXOSMITHKLINE-US2021164798: US-GLAXOSMITHKLINE-US2021164799: US-GLAXOSMITHKLINE-US2021164800: US-GLAXOSMITHKLINE-US2021164801: US-GLAXOSMITHKLINE-US2021164802: US-GLAXOSMITHKLINE-US2021164803: US-GLAXOSMITHKLINE-US2021164804: US-GLAXOSMITHKLINE-US2021164805: US-GLAXOSMITHKLINE-US2021164806: US-GLAXOSMITHKLINE-US2021164808: US-GLAXOSMITHKLINE-US2021164801: US-GLAXOSMITHKLINE-US2021164802:
Normal well baby visit. Next day my daughter developed a rash around injection site. I called her PCP but they told me it wasn't related. Even though it was the exact injection site. they said to keep an eye on it. She then fell ill with vomiting, irritability and fever the next day, continued for over a week. So we made an appointment with her doctor (on vacation) so we got the person on call. Visit is documented. Fever was 102 to 103.
flu shot took the patient for a loop; Initial information received on 09-Sep-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional.  This case involves a 72-years-old female patient.  The flu shoot took the patient for a loop (unevaluable event), while she received INFLUENZA VACCINE.  The patient's medical treatment, vaccination, concomitant medication and family history were not provided. At the time of the event, the patient had ongoing medical history of four Autoimmune disorder, Thyroid disorder, Arthritis and Raynaud's phenomenon.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, it was reported that the flu shoot took the patient for a loop (unevaluable event) unknown latency following the administration of INFLUENZA VACCINE.   Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for the event.  There will be no information on the batch number for this case.
Fever, cough, diarrhea, sore throat, headache, and vomiting. Low BP 76/54, exertional dyspena
A week after I recieved the shot I started coughing and feeling terrible. That lasted for 1 day, however, my arm developed a large rash. It is now 2/09/2021 and the rash is still on my arm.
Back of left arm tingled after injection.  No shortness of breath /dizziness/lightheadedness A&O  Client left at 4:45pm arm no longer tingling. No shortness of breath
Itchiness starting about 7 days after first dose mild during the day but very hard to sleep at night itches all over body
Experienced whole body itching and redness; Experienced whole body itching and redness; A spontaneous report was received from a consumer, concerning a male patient 65-year-old, who received Moderna's COVID-19 vaccine and experienced whole-body itching and redness.  The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On 17 FEB 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (lot/batch: 023M20A) via unknown route for prophylaxis of COVID-19 infection   On 23 FEB 2021, the patient experienced whole-body itching and redness. Treatment details included Benadryl. Action taken with mRNA-1273 in response to the events was not reported.    At the time of the report, the outcome of event was unknown.
At 1615 (3/23/21),  experienced left leg heaviness, intermittent chest pain, body aches, fever 102.5, headache, chills, rigors, and tachycardia - most symptoms lasted only 36 hours. Left leg heaviness persisted and is still present. Intermittent chest pain x 10 days. Near syncope lasting  from days 4-11 post vaccine - with one syncopal event occurring  on day 5. Tachycardia and palpitations persist. April 14 - chest pain returned. On April 15 -  Went to Emergency Department for heart rate of 172, shortness of breath, and palpitiations.  Persistent left leg heaviness since vaccination.  Evaluated for potential pulmonary embolism, myocardial infarction, DVT, and post Covid vaccine infectious pericarditis,  Admitted to Hospital overnight.  Tested negative for Covid-19. Left leg heaviness persists.  Intermittent tachycardia persists. May 10  developed a cold sore 1 day post sun exposure (normal for me).  Evening of May 11 - fever, tachycardia, body  aches, headache, chills. May 11 - negative Covid test May 20 - message from CDC requesting I fill out a VAERS.
No additional AE; HCP was administered a dose of PROQUAD on 29MAR2021 at the age of 19 years old and then administered a second dose of PROQUAD on 20FEB2023; This spontaneous report was received from a physician and refers to a 19-year-old patient of unknown gender, whose medical history, concurrent conditions, and concomitant therapies were not reported.  On 29-MAR-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, administered for prophylaxis (strength, dose, frequency, lot number, expiration date, anatomical injection site, and route of administration were not provided). On 20-FEB-2023, the patient received a second dose of the suspect vaccine (inappropriate age at vaccine administration). No additional adverse event (AE) were reported (no adverse event).
Patient experienced a large welt on upper arm that itched and hurt for several days.  There is still a big mark on deltoid of arm from where patient received vaccine over 1 week ago.
A little bit more of a reaction,much more severe; Truck ran over,felt 90% (at the end of the day),lay down for a couple of hours; For the booster dose, patient had a sore arm arm (left) immediately; It says 0.5 mL (instead of half dose); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (A little bit more of a reaction,much more severe), FEELING ABNORMAL (Truck ran over,felt 90% (at the end of the day),lay down for a couple of hours), VACCINATION SITE PAIN (For the booster dose, patient had a sore arm arm (left) immediately) and ACCIDENTAL OVERDOSE (It says 0.5 mL (instead of half dose)) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, 002B21A and 040B21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, IRBESARTAN and ATORVASTATIN for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, the patient experienced VACCINATION SITE PAIN (For the booster dose, patient had a sore arm arm (left) immediately) and ACCIDENTAL OVERDOSE (It says 0.5 mL (instead of half dose)). On 05-Dec-2021, the patient experienced VACCINATION COMPLICATION (A little bit more of a reaction,much more severe) and FEELING ABNORMAL (Truck ran over,felt 90% (at the end of the day),lay down for a couple of hours). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) at a dose of Couple of Motrin. On 04-Dec-2021, ACCIDENTAL OVERDOSE (It says 0.5 mL (instead of half dose)) had resolved. At the time of the report, VACCINATION COMPLICATION (A little bit more of a reaction,much more severe), FEELING ABNORMAL (Truck ran over,felt 90% (at the end of the day),lay down for a couple of hours) and VACCINATION SITE PAIN (For the booster dose, patient had a sore arm arm (left) immediately) outcome was unknown.            No medical history was provided by the reporter.  The patient stated that they went to get the Moderna booster shot and when they saw their vaccination card, it said that they got a full dose of 0.5 mL. The patient stated that they had a little bit more of a reaction to the booster and also mentioned that for the booster, the agent couldn't confirm if it was full dose or half dose, the patient had a sore arm on the left immediately. On 05-Dec-2021 the patient felt like a truck ran over them and had to lay down for a couple of hours. And it had to pass most of the day for them to feel around 90% of how they usually felt, and it was much more severe than the first two shots.  It was also reported that the patient had couple of Motrin and it helped.   This case was linked to MOD-2021-405279, MOD-2021-405832 (Patient Link).
3-31-09 Mom states light rash on face yesterday prior to vaccines (not mentioned or noticed prior to injection) this morning (4-1-09) child has fine rash all over body (trunk, limbs) with fever - has not given TYLENOL drops as recommended - will start TYLENOL ASAP - (fever amt unknown)
approx 15mos p/vax pt devel a mild case of chickenpox w/20-25 lesions all over & fever.
Pt was given the Hepatitis b correctly. However, it didn'nt convert. Now is hepatitis B Positive from disease
Received PREVNAR shot from PCP prior to traveling and developed injection site cellulitis on the left arm deltoid two days after shot.
Patient recieved the flu vaccine at 715am on 9/24/2018, and about 230pm on 9/25/2018 he said that he got hives on neck, upper and lower extremities and trunk.
Tingling and tightness in scalp. Fullness feeling in head. Had acupuncture and helped for 2 weeks.  Fullness and tingling comes and goes. Some days none then repeats.  Saw doctor she recommended over the counter Lipoic Acid. I am taking 240 mg Life Extension super R-Lipoic Acid 2 x day.  Does not seem to help. Used for 2 weeks and will continue and increase to 3x day.
Onset same day as vaccination within 15 min c/o headache. Local reaction rash around injection site - onset of s/sx same day as injection given pt. states she started having ear pain, fatigue and joint and muscle pain, (R) side of body. Has Hx of fibromyalgia and has been going through a lot of high stress lately. Seen by FNP - here 2/21/14 - pt. 1st called re: reaction - 2/20/14 - in PM offered appt. declined called later in PM and scheduled 2/21/14 appt.
My 12 year old daughter received her second Gardasil shot on Saturday morning. She had localized pain in her arm at the injection site but no other issues. On Sunday, her entire arm was in pain with areas of numbness. On Monday, the fever started. Typical temperature when not being brought down by ibuprofen is 102.6 degrees F- 103 degrees F. It is now Monday morning, she has maintained a fever that spikes whenever the ibuprofen isn't at peak effectiveness, and her toe, leg, and injection-site arm are all throbbing in pain. I took her back to the pediatrician yesterday (same practice that administered the vaccine) and was told that a side effect from GARDASIL would not include such a high fever and that she probably just has a coincidentally-timed virus. Strep and flu tests came back negative.
After 5 days, I have had pain in my right arm to my chest and the same pain from my right arm to my back. This pain does subside when I take Advil but then will return later that day. I have now had this pain for almost 3 weeks.
Swelling in my nodes. Pain in my armpit on the side I got my first shot. Achy joints.
No additional AE's; The vaccine that underwent a temperature excursion (2C to 8C (12.6C) for 480 hours) and was administered.; This spontaneous report was received from an office manager and refers to a patient of an unknown age and gender. No information regarding the patient's medical history, concurrent conditions, concomitant medication, drug reactions or allergies was not reported.  On 05-MAY-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # 1687290 was confirmed to be valid, expiration date 06-SEP-2022 (dose, route and site of administration were not reported) for prophylaxis. The temperature excursion was reported as "2 degrees Celsius (C) to 8 C (12.6 C) for 480 hours. There was no previous temperature excursion. No additional adverse event was reported. The call was because of a digital data logger.  This is one of three reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck  devicelotnumber: 1687290; expirationdate: 06-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
1-2 weeks after HBV injection began experienceing "flu-like sxs" including total body aching especially neck and shoulders. Has URI sxs. States developed pneumonia 2-3 weeks after second HBV in 8/03.
On  11/1/21 was walking  up stairs to gym, had a difficult time catching  my breath, then felt light headed.  Continued a normal day.  11/4 symptoms returned and worsened over the weekend. 11/8 walking 4 blocks, had to stop every 20 feet to rest and catch my breath. Coworker called EMS.   Immediately after receiving both flu and covid vaccines I felt extremely tired.
01/19/21 1:30 pm  Body ache, temp. 99°F, chills, headache for tow days.  Verbalize feeling well and recovered.
GRANDMOTHER REPORTED PATIENT WAS HAVING WHAT SHE THINKS IS A REACTION TO HER FLU SHOT WEAK, ACHY, TEMP OF 100 -SHE CALLED -I ADVISED HER TO CALL MD WHICH SHE DID AND THEY ADVISED HER TO WATCH PATIENT -SHE CALLED AND SAID PATIENT WAS SLEEPING AND LATER AT 5PM SAID SHE WAS FEELING BETTER
Pt vaccinated with MMR developed multiple brief febrile seizures 9 days later. Also subsequent rt facial nerve palsy.
I had been standing for a minute or so and I noticed I was having a hard time breathing. I tested what might be going on by laying on the floor and elevating my feet. Within five minutes it was easier to breath. When I felt like I could move again I got my Florinef and drank a liter of water and went to bed and there was no reoccurrence.
Injection site swelling with a hard knot; Injection site rash; Joint pain; Fever; Chills; Injection site swelling with a hard knot; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 6 months after receiving Shingrix, the patient experienced injection site swelling, injection site rash, joint pain, fever, chills and injection site lump. On an unknown date, the outcome of the injection site swelling, injection site rash, joint pain, fever, chills and injection site lump were recovered/resolved.   It was unknown if the reporter considered the injection site swelling, injection site rash, joint pain, fever, chills and injection site lump to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The caller was a patient who had first dose of Shingrix some time in left arm. The patient experienced injection site swelling with a hard knot, injection site rash, joint pain, fever and chills and that these events resolved in around 3 days. The reporter did not consent to follow-up. The caller declined to provide any demographics.